APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Medical Radioisotopes

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Medical Radioisotopes Market Analysis and Forecast 2026-2032

Report ID 173894740221 December 2025195 pages

Choose your research edition.

Industry ResearchMedical Radioisotopes Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Radioisotopes Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Medical Radioisotopes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Radioisotopes Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Radioisotopes Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Medical Radioisotopes market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Medical Radioisotopes is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Medical Radioisotopes is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Medical Radioisotopes is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Medical Radioisotopes is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Medical Radioisotopes include NRG, IRE, ANSTO, NTP Radioisotopes, China National Nuclear Corporation, Rosatom, Nordion, Eckert & Ziegler Strahlen and Polatom, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Medical Radioisotopes, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Medical Radioisotopes, also provides the revenue of main regions and countries. Of the upcoming market potential for Medical Radioisotopes, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Medical Radioisotopes revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Medical Radioisotopes market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Medical Radioisotopes revenue, projected growth trends, production technology, application and end-user industry.

Medical Radioisotopes Segment by Company

NRG

IRE

ANSTO

NTP Radioisotopes

China National Nuclear Corporation

Rosatom

Nordion

Eckert & Ziegler Strahlen

Polatom

Medical Radioisotopes Segment by Type

Tc-99m

Cobalt-60

Iodine Radioisotopes

Medical Radioisotopes Segment by Application

Nuclear Therapy

Equipment Radioactive Source

Diagnosis

Others

Medical Radioisotopes Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Radioisotopes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Radioisotopes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Radioisotopes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Medical Radioisotopes in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Medical Radioisotopes company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Radioisotopes revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Medical Radioisotopes Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tc-99m Major Player Table 3. Cobalt-60 Major Player Table 4. Iodine Radioisotopes Major Player Table 5. Global Medical Radioisotopes Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Nuclear Therapy Major Player Table 7. Equipment Radioactive Source Major Player Table 8. Diagnosis Major Player Table 9. Others Major Player Table 10. Medical Radioisotopes Industry Trends Table 11. Medical Radioisotopes Industry Drivers Table 12. Medical Radioisotopes Industry Opportunities and Challenges Table 13. Medical Radioisotopes Industry Restraints Table 14. Global Medical Radioisotopes Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Medical Radioisotopes Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Medical Radioisotopes Market Share by Region (2021-2026) Table 17. Global Medical Radioisotopes Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Medical Radioisotopes Market Share by Region (2027-2032) Table 19. Global Medical Radioisotopes Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Medical Radioisotopes Revenue Market Share by Players (2021-2026) Table 21. Global Medical Radioisotopes Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Medical Radioisotopes Key Players Headquarters & Area Served Table 23. Global Medical Radioisotopes Players, Product Type & Application Table 24. Global Medical Radioisotopes Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Medical Radioisotopes by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Medical Radioisotopes Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Medical Radioisotopes Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Medical Radioisotopes Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Medical Radioisotopes Revenue Market Share by Type (2021-2026) Table 31. Global Medical Radioisotopes Revenue Market Share by Type (2027-2032) Table 32. Global Medical Radioisotopes Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Medical Radioisotopes Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Medical Radioisotopes Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Medical Radioisotopes Revenue Market Share by Application (2021-2026) Table 36. Global Medical Radioisotopes Revenue Market Share by Application (2027-2032) Table 37. NRG Company Information Table 38. NRG Business Overview Table 39. NRG Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. NRG Medical Radioisotopes Product Portfolio Table 41. NRG Recent Development Table 42. IRE Company Information Table 43. IRE Business Overview Table 44. IRE Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. IRE Medical Radioisotopes Product Portfolio Table 46. IRE Recent Development Table 47. ANSTO Company Information Table 48. ANSTO Business Overview Table 49. ANSTO Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. ANSTO Medical Radioisotopes Product Portfolio Table 51. ANSTO Recent Development Table 52. NTP Radioisotopes Company Information Table 53. NTP Radioisotopes Business Overview Table 54. NTP Radioisotopes Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. NTP Radioisotopes Medical Radioisotopes Product Portfolio Table 56. NTP Radioisotopes Recent Development Table 57. China National Nuclear Corporation Company Information Table 58. China National Nuclear Corporation Business Overview Table 59. China National Nuclear Corporation Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. China National Nuclear Corporation Medical Radioisotopes Product Portfolio Table 61. China National Nuclear Corporation Recent Development Table 62. Rosatom Company Information Table 63. Rosatom Business Overview Table 64. Rosatom Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Rosatom Medical Radioisotopes Product Portfolio Table 66. Rosatom Recent Development Table 67. Nordion Company Information Table 68. Nordion Business Overview Table 69. Nordion Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Nordion Medical Radioisotopes Product Portfolio Table 71. Nordion Recent Development Table 72. Eckert & Ziegler Strahlen Company Information Table 73. Eckert & Ziegler Strahlen Business Overview Table 74. Eckert & Ziegler Strahlen Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Eckert & Ziegler Strahlen Medical Radioisotopes Product Portfolio Table 76. Eckert & Ziegler Strahlen Recent Development Table 77. Polatom Company Information Table 78. Polatom Business Overview Table 79. Polatom Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Polatom Medical Radioisotopes Product Portfolio Table 81. Polatom Recent Development Table 82. North America Medical Radioisotopes Revenue by Type (2021-2026) & (US$ Million) Table 83. North America Medical Radioisotopes Revenue by Type (2027-2032) & (US$ Million) Table 84. North America Medical Radioisotopes Revenue by Application (2021-2026) & (US$ Million) Table 85. North America Medical Radioisotopes Revenue by Application (2027-2032) & (US$ Million) Table 86. North America Medical Radioisotopes Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. North America Medical Radioisotopes Revenue by Country (2021-2026) & (US$ Million) Table 88. North America Medical Radioisotopes Revenue by Country (US$ Million) & (2027-2032) Table 89. Europe Medical Radioisotopes Revenue by Type (2021-2026) & (US$ Million) Table 90. Europe Medical Radioisotopes Revenue by Type (2027-2032) & (US$ Million) Table 91. Europe Medical Radioisotopes Revenue by Application (2021-2026) & (US$ Million) Table 92. Europe Medical Radioisotopes Revenue by Application (2027-2032) & (US$ Million) Table 93. Europe Medical Radioisotopes Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. Europe Medical Radioisotopes Revenue by Country (2021-2026) & (US$ Million) Table 95. Europe Medical Radioisotopes Revenue by Country (US$ Million) & (2027-2032) Table 96. China Medical Radioisotopes Revenue by Type (2021-2026) & (US$ Million) Table 97. China Medical Radioisotopes Revenue by Type (2027-2032) & (US$ Million) Table 98. China Medical Radioisotopes Revenue by Application (2021-2026) & (US$ Million) Table 99. China Medical Radioisotopes Revenue by Application (2027-2032) & (US$ Million) Table 100. Asia Medical Radioisotopes Revenue by Type (2021-2026) & (US$ Million) Table 101. Asia Medical Radioisotopes Revenue by Type (2027-2032) & (US$ Million) Table 102. Asia Medical Radioisotopes Revenue by Application (2021-2026) & (US$ Million) Table 103. Asia Medical Radioisotopes Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Medical Radioisotopes Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 105. Asia Medical Radioisotopes Revenue by Region (US$ Million) & (2021-2026) Table 106. Asia Medical Radioisotopes Revenue by Region (US$ Million) & (2027-2032) Table 107. SAMEA Medical Radioisotopes Revenue by Type (2021-2026) & (US$ Million) Table 108. SAMEA Medical Radioisotopes Revenue by Type (2027-2032) & (US$ Million) Table 109. SAMEA Medical Radioisotopes Revenue by Application (2021-2026) & (US$ Million) Table 110. SAMEA Medical Radioisotopes Revenue by Application (2027-2032) & (US$ Million) Table 111. SAMEA Medical Radioisotopes Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. SAMEA Medical Radioisotopes Revenue by Country (2021-2026) & (US$ Million) Table 113. SAMEA Medical Radioisotopes Revenue by Country (US$ Million) & (2027-2032) Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Medical Radioisotopes Image Figure 2. Global Medical Radioisotopes Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Radioisotopes Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tc-99m Image Figure 5. Cobalt-60 Image Figure 6. Iodine Radioisotopes Image Figure 7. Global Medical Radioisotopes Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Medical Radioisotopes Market Size Share 2021 VS 2025 VS 2032 Figure 9. Nuclear Therapy Image Figure 10. Equipment Radioactive Source Image Figure 11. Diagnosis Image Figure 12. Others Image Figure 13. Global Medical Radioisotopes Market Size (US$ Million) & (2021-2032) Figure 14. Global Medical Radioisotopes Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Medical Radioisotopes Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Medical Radioisotopes Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Medical Radioisotopes Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Medical Radioisotopes Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Medical Radioisotopes Revenue Market Share by Type (2021-2032) Figure 21. Global Medical Radioisotopes Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Medical Radioisotopes Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Medical Radioisotopes Revenue Market Share by Application (2021-2032) Figure 24. North America Medical Radioisotopes Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Medical Radioisotopes Revenue Share by Type (2021-2032) Figure 26. North America Medical Radioisotopes Revenue Share by Application (2021-2032) Figure 27. North America Medical Radioisotopes Revenue Share by Country (2021-2032) Figure 28. United States Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Medical Radioisotopes Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Medical Radioisotopes Revenue Share by Type (2021-2032) Figure 33. Europe Medical Radioisotopes Revenue Share by Application (2021-2032) Figure 34. Europe Medical Radioisotopes Revenue Share by Country (2021-2032) Figure 35. Germany Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Medical Radioisotopes Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Medical Radioisotopes Revenue Share by Type (2021-2032) Figure 45. China Medical Radioisotopes Revenue Share by Application (2021-2032) Figure 46. Asia Medical Radioisotopes Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Medical Radioisotopes Revenue Share by Type (2021-2032) Figure 48. Asia Medical Radioisotopes Revenue Share by Application (2021-2032) Figure 49. Asia Medical Radioisotopes Revenue Share by Region (2021-2032) Figure 50. Japan Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Medical Radioisotopes Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Medical Radioisotopes Revenue Share by Type (2021-2032) Figure 58. SAMEA Medical Radioisotopes Revenue Share by Application (2021-2032) Figure 59. SAMEA Medical Radioisotopes Revenue Share by Country (2021-2032) Figure 60. Brazil Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Tc-99m
  • Cobalt-60
  • Iodine Radioisotopes
Applications
  • Nuclear Therapy
  • Equipment Radioactive Source
  • Diagnosis
  • Others
Companies covered
  • NRG
  • IRE
  • ANSTO
  • NTP Radioisotopes
  • China National Nuclear Corporation
  • Rosatom
  • Nordion
  • Eckert & Ziegler Strahlen
  • Polatom

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Medical Radioisotopes Market by Type
  3. 1.2.1 Global Medical Radioisotopes Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tc-99m
  5. 1.2.3 Cobalt-60
  6. 1.2.4 Iodine Radioisotopes
  7. 1.3 Medical Radioisotopes Market by Application
  8. 1.3.1 Global Medical Radioisotopes Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Nuclear Therapy
  10. 1.3.3 Equipment Radioactive Source
  11. 1.3.4 Diagnosis
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Medical Radioisotopes Market Dynamics
  1. 2.1 Medical Radioisotopes Industry Trends
  2. 2.2 Medical Radioisotopes Industry Drivers
  3. 2.3 Medical Radioisotopes Industry Opportunities and Challenges
  4. 2.4 Medical Radioisotopes Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Medical Radioisotopes Market Perspective (2021-2032)
  2. 3.2 Global Medical Radioisotopes Growth Trends by Region
  3. 3.2.1 Global Medical Radioisotopes Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Medical Radioisotopes Market Size by Region (2021-2026)
  5. 3.2.3 Global Medical Radioisotopes Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Medical Radioisotopes Revenue by Players
  2. 4.1.1 Global Medical Radioisotopes Revenue by Players (2021-2026)
  3. 4.1.2 Global Medical Radioisotopes Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Medical Radioisotopes Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Medical Radioisotopes Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Medical Radioisotopes Key Players Headquarters & Area Served
  7. 4.4 Global Medical Radioisotopes Players, Product Type & Application
  8. 4.5 Global Medical Radioisotopes Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Medical Radioisotopes Market CR5 and HHI
  11. 4.6.3 2025 Medical Radioisotopes Tier 1, Tier 2, and Tier 3
5 Medical Radioisotopes Market Size by Type
  1. 5.1 Global Medical Radioisotopes Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Medical Radioisotopes Revenue by Type (2021-2032)
  3. 5.3 Global Medical Radioisotopes Revenue Market Share by Type (2021-2032)
6 Medical Radioisotopes Market Size by Application
  1. 6.1 Global Medical Radioisotopes Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Medical Radioisotopes Revenue by Application (2021-2032)
  3. 6.3 Global Medical Radioisotopes Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 NRG
  2. 7.1.1 NRG Company Information
  3. 7.1.2 NRG Business Overview
  4. 7.1.3 NRG Medical Radioisotopes Revenue and Gross Margin (2021-2026)
  5. 7.1.4 NRG Medical Radioisotopes Product Portfolio
  6. 7.1.5 NRG Recent Developments
  7. 7.2 IRE
  8. 7.2.1 IRE Company Information
  9. 7.2.2 IRE Business Overview
  10. 7.2.3 IRE Medical Radioisotopes Revenue and Gross Margin (2021-2026)
  11. 7.2.4 IRE Medical Radioisotopes Product Portfolio
  12. 7.2.5 IRE Recent Developments
  13. 7.3 ANSTO
  14. 7.3.1 ANSTO Company Information
  15. 7.3.2 ANSTO Business Overview
  16. 7.3.3 ANSTO Medical Radioisotopes Revenue and Gross Margin (2021-2026)
  17. 7.3.4 ANSTO Medical Radioisotopes Product Portfolio
  18. 7.3.5 ANSTO Recent Developments
  19. 7.4 NTP Radioisotopes
  20. 7.4.1 NTP Radioisotopes Company Information
  21. 7.4.2 NTP Radioisotopes Business Overview
  22. 7.4.3 NTP Radioisotopes Medical Radioisotopes Revenue and Gross Margin (2021-2026)
  23. 7.4.4 NTP Radioisotopes Medical Radioisotopes Product Portfolio
  24. 7.4.5 NTP Radioisotopes Recent Developments
  25. 7.5 China National Nuclear Corporation
  26. 7.5.1 China National Nuclear Corporation Company Information
  27. 7.5.2 China National Nuclear Corporation Business Overview
  28. 7.5.3 China National Nuclear Corporation Medical Radioisotopes Revenue and Gross Margin (2021-2026)
  29. 7.5.4 China National Nuclear Corporation Medical Radioisotopes Product Portfolio
  30. 7.5.5 China National Nuclear Corporation Recent Developments
  31. 7.6 Rosatom
  32. 7.6.1 Rosatom Company Information
  33. 7.6.2 Rosatom Business Overview
  34. 7.6.3 Rosatom Medical Radioisotopes Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Rosatom Medical Radioisotopes Product Portfolio
  36. 7.6.5 Rosatom Recent Developments
  37. 7.7 Nordion
  38. 7.7.1 Nordion Company Information
  39. 7.7.2 Nordion Business Overview
  40. 7.7.3 Nordion Medical Radioisotopes Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Nordion Medical Radioisotopes Product Portfolio
  42. 7.7.5 Nordion Recent Developments
  43. 7.8 Eckert & Ziegler Strahlen
  44. 7.8.1 Eckert & Ziegler Strahlen Company Information
  45. 7.8.2 Eckert & Ziegler Strahlen Business Overview
  46. 7.8.3 Eckert & Ziegler Strahlen Medical Radioisotopes Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Eckert & Ziegler Strahlen Medical Radioisotopes Product Portfolio
  48. 7.8.5 Eckert & Ziegler Strahlen Recent Developments
  49. 7.9 Polatom
  50. 7.9.1 Polatom Company Information
  51. 7.9.2 Polatom Business Overview
  52. 7.9.3 Polatom Medical Radioisotopes Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Polatom Medical Radioisotopes Product Portfolio
  54. 7.9.5 Polatom Recent Developments
8 North America
  1. 8.1 North America Medical Radioisotopes Revenue (2021-2032)
  2. 8.2 North America Medical Radioisotopes Revenue by Type (2021-2032)
  3. 8.2.1 North America Medical Radioisotopes Revenue by Type (2021-2026)
  4. 8.2.2 North America Medical Radioisotopes Revenue by Type (2027-2032)
  5. 8.3 North America Medical Radioisotopes Revenue Share by Type (2021-2032)
  6. 8.4 North America Medical Radioisotopes Revenue by Application (2021-2032)
  7. 8.4.1 North America Medical Radioisotopes Revenue by Application (2021-2026)
  8. 8.4.2 North America Medical Radioisotopes Revenue by Application (2027-2032)
  9. 8.5 North America Medical Radioisotopes Revenue Share by Application (2021-2032)
  10. 8.6 North America Medical Radioisotopes Revenue by Country
  11. 8.6.1 North America Medical Radioisotopes Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Medical Radioisotopes Revenue by Country (2021-2026)
  13. 8.6.3 North America Medical Radioisotopes Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Medical Radioisotopes Revenue (2021-2032)
  2. 9.2 Europe Medical Radioisotopes Revenue by Type (2021-2032)
  3. 9.2.1 Europe Medical Radioisotopes Revenue by Type (2021-2026)
  4. 9.2.2 Europe Medical Radioisotopes Revenue by Type (2027-2032)
  5. 9.3 Europe Medical Radioisotopes Revenue Share by Type (2021-2032)
  6. 9.4 Europe Medical Radioisotopes Revenue by Application (2021-2032)
  7. 9.4.1 Europe Medical Radioisotopes Revenue by Application (2021-2026)
  8. 9.4.2 Europe Medical Radioisotopes Revenue by Application (2027-2032)
  9. 9.5 Europe Medical Radioisotopes Revenue Share by Application (2021-2032)
  10. 9.6 Europe Medical Radioisotopes Revenue by Country
  11. 9.6.1 Europe Medical Radioisotopes Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Medical Radioisotopes Revenue by Country (2021-2026)
  13. 9.6.3 Europe Medical Radioisotopes Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Medical Radioisotopes Revenue (2021-2032)
  2. 10.2 China Medical Radioisotopes Revenue by Type (2021-2032)
  3. 10.2.1 China Medical Radioisotopes Revenue by Type (2021-2026)
  4. 10.2.2 China Medical Radioisotopes Revenue by Type (2027-2032)
  5. 10.3 China Medical Radioisotopes Revenue Share by Type (2021-2032)
  6. 10.4 China Medical Radioisotopes Revenue by Application (2021-2032)
  7. 10.4.1 China Medical Radioisotopes Revenue by Application (2021-2026)
  8. 10.4.2 China Medical Radioisotopes Revenue by Application (2027-2032)
  9. 10.5 China Medical Radioisotopes Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Medical Radioisotopes Revenue (2021-2032)
  2. 11.2 Asia Medical Radioisotopes Revenue by Type (2021-2032)
  3. 11.2.1 Asia Medical Radioisotopes Revenue by Type (2021-2026)
  4. 11.2.2 Asia Medical Radioisotopes Revenue by Type (2027-2032)
  5. 11.3 Asia Medical Radioisotopes Revenue Share by Type (2021-2032)
  6. 11.4 Asia Medical Radioisotopes Revenue by Application (2021-2032)
  7. 11.4.1 Asia Medical Radioisotopes Revenue by Application (2021-2026)
  8. 11.4.2 Asia Medical Radioisotopes Revenue by Application (2027-2032)
  9. 11.5 Asia Medical Radioisotopes Revenue Share by Application (2021-2032)
  10. 11.6 Asia Medical Radioisotopes Revenue by Country
  11. 11.6.1 Asia Medical Radioisotopes Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Medical Radioisotopes Revenue by Country (2021-2026)
  13. 11.6.3 Asia Medical Radioisotopes Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Medical Radioisotopes Revenue (2021-2032)
  2. 12.2 SAMEA Medical Radioisotopes Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Medical Radioisotopes Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Medical Radioisotopes Revenue by Type (2027-2032)
  5. 12.3 SAMEA Medical Radioisotopes Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Medical Radioisotopes Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Medical Radioisotopes Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Medical Radioisotopes Revenue by Application (2027-2032)
  9. 12.5 SAMEA Medical Radioisotopes Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Medical Radioisotopes Revenue by Country
  11. 12.6.1 SAMEA Medical Radioisotopes Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Medical Radioisotopes Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Medical Radioisotopes Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst